Author:
He Zhen-Yu,Zhuo Ren-Gong,Yang Shi-Ping,Zhou Ping,Xu Jing-Ying,Zhou Juan,Wu San-Gang
Reference57 articles.
1. CircDUSP1 regulates tumor growth, metastasis, and paclitaxel sensitivity in triple-negative breast cancer by targeting miR-761/DACT2 signaling axis;Huang;Mol. Carcinog.,2023
2. Pathology of breast cancer: subtypes, receptors, biologic markers, and staging;Bakhtar;Surg. Clin. North Am.,2023
3. A review of prognostic and predictive biomarkers in breast cancer;Tarighati;Clin. Exp. Med.,2023
4. Targeting triple-negative breast cancer: optimising therapeutic outcomes;Gelmon;Ann. Oncol.,2012
5. Adjuvant Capecitabine with docetaxel and cyclophosphamide plus epirubicin for triple-negative breast cancer (CBCSG010): an open-label, randomized, multicenter, phase III trial;Li;J. Clin. Oncol.,2020
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献